优势供应,量大从优,欢迎咨询
PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM). PT2977, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile.
开封明仁药业有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!